| scholarly article | Q13442814 |
| P2093 | author name string | Jiao Wang | |
| Shu Liu | |||
| Ting Luo | |||
| Hui Hua | |||
| Qingbin Kong | |||
| Ting Shao | |||
| Xiaodong Huo | |||
| Yangfu Jiang | |||
| P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
| GSK-3: tricks of the trade for a multi-tasking kinase | Q24624069 | ||
| The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor | Q24682781 | ||
| Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics | Q24685475 | ||
| Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
| Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism | Q28114789 | ||
| Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene | Q28118453 | ||
| Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease | Q28218236 | ||
| GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity | Q42824819 | ||
| High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics. | Q47758619 | ||
| GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1. | Q51360193 | ||
| Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. | Q53356648 | ||
| From worm to human: bioinformatics approaches to identify FOXO target genes | Q81176620 | ||
| TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth | Q28262401 | ||
| FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis | Q28285131 | ||
| Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead | Q28506168 | ||
| GSK-3-mediated phosphorylation enhances Maf-transforming activity | Q28576703 | ||
| The renaissance of GSK3 | Q29616725 | ||
| FOXOs, cancer and regulation of apoptosis | Q33642512 | ||
| Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. | Q34084120 | ||
| AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias | Q34212654 | ||
| Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis | Q34372865 | ||
| GSK3 takes centre stage more than 20 years after its discovery | Q34374129 | ||
| AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity | Q34511038 | ||
| Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma. | Q34637826 | ||
| A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression | Q34656781 | ||
| Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation | Q35571394 | ||
| Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells | Q35816378 | ||
| Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1. | Q35889450 | ||
| MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. | Q36176619 | ||
| Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product | Q36378010 | ||
| GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. | Q36512934 | ||
| Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor | Q36696132 | ||
| Dynamic FoxO transcription factors | Q36889897 | ||
| Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. | Q37001651 | ||
| Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation | Q37106907 | ||
| Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy | Q37163149 | ||
| The PKB/FOXO switch in aging and cancer | Q37871660 | ||
| AKT down-regulates insulin-like growth factor-1 receptor as a negative feedback | Q39535703 | ||
| TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia | Q39744014 | ||
| Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells | Q39801970 | ||
| FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage. | Q39813880 | ||
| Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. | Q39906003 | ||
| SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock | Q40118969 | ||
| Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. | Q40134202 | ||
| Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells | Q40264789 | ||
| The regulation of IGF-I receptor gene expression. | Q40381637 | ||
| Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells | Q40444210 | ||
| A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation | Q40795858 | ||
| AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. | Q40824440 | ||
| Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. | Q41012238 | ||
| The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein | Q41175804 | ||
| Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation | Q42183550 | ||
| Can a two-faced kinase be exploited for osteosarcoma? | Q42387864 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 24759-24770 | |
| P577 | publication date | 2014-07-22 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4 | |
| P478 | volume | 289 |
| Q41526032 | DAF-16/FOXO Transcription Factor in Aging and Longevity |
| Q28074586 | Epstein-Barr Virus: Diseases Linked to Infection and Transformation |
| Q47095382 | Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy |
| Q90019609 | GSK-3β inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity |
| Q90644165 | GSK3-β promotes calpain-1-mediated desmin filament depolymerization and myofibril loss in atrophy |
| Q33829976 | Inhibition of ERK1/2 Restores GSK3β Activity and Protein Synthesis Levels in a Model of Tuberous Sclerosis |
| Q92237212 | MAT2B expression correlates with poor prognosis in triple-negative breast cancer |
| Q97644577 | Modulated Expression of the Protein Kinase GSK3 in Motor and Dopaminergic Neurons Increases Female Lifespan in Drosophila melanogaster |
| Q91639718 | Protein synthesis signaling in skeletal muscle is refractory to whey protein ingestion during a severe energy deficit evoked by prolonged exercise and caloric restriction |
| Q26799843 | Redox regulation of FoxO transcription factors |
| Q50057271 | Regulation of FOXO Factors in Mammalian Cells. |
| Q54114703 | Requirement of GSK-3 for PUMA induction upon loss of pro-survival PI3K signaling. |
| Q38800014 | Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation. |
| Q58745106 | Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways |
| Q43950297 | The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects |
Search more.